Document Detail

Modular extracorporeal life support for multiorgan failure patients.
MedLine Citation:
PMID:  12220309     Owner:  NLM     Status:  MEDLINE    
Adults receiving respiratory Extracorporeal Membrane Oxygenation (ECMO) have 66% survival. Nonsurvivors develop multisystem organ failure (MSOF). Once hepatic failure develops, death usually follows shortly. Serum bilirubin > 300 micromol/l predicted death with 87.8% sensitivity and 90.3% specificity in 41 adults who received ECMO in our institution during 1998 and 1999. No patients survive with a peak bilirubin > 400 micromol/l. The Molecular Adsorbent Recirculating System (MARS) is a cell-free extracorporeal liver support device; we hypothesized that using MARS in adult respiratory ECMO patients with a bilirubin >300 micromol/l could improve survival in MSOF. The MARS was used in five such patients aged 19-56 who developed liver failure secondary to a respiratory illness. Mean peak bilirubin was 529 micromol/l and the lowest peak bilirubin was 436 micromol/l. Patients received between 1 and 8 MARS treatments, mean reduction in serum bilirubin for each patient ranging between 30 and 162 micromol/l. Two of five patients survived (40%), survivors showing the greatest reduction in serum bilirubin in response to MARS. All patients would have been expected to die according to our previous experience. We believe that MARS may prove a useful therapy for patients with MSOF.
Giles J Peek; Hillary M Killer; Marcin A Sosnowski; Richard K Firmin
Related Documents :
19861959 - Predicting fibrosis worsening in obese patients with nash through parenchymal fibronect...
17890949 - Hemostasis and global fibrinolytic capacity in chronic liver disease.
9189129 - Clinical impact of somatostatin receptor scintigraphy in the management of patients wit...
19159729 - Spectrum of hepatic hemangiomas: management and outcome.
15492609 - Prevalence and natural history of gastric antral vascular ectasia in patients undergoin...
1006209 - Liver involvement in polymyalgia rheumatica.
22634379 - Cardiac troponin t measured by a high-sensitivity assay predicts recurrent cardiovascul...
3261449 - Albumin prevents erythrocyte crenation in patients undergoing extracorporeal circulation.
10765069 - Correlation between chronic prostatitis syndrome and pelvic venous disease: a survey of...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Liver     Volume:  22 Suppl 2     ISSN:  0106-9543     ISO Abbreviation:  Liver     Publication Date:  2002  
Date Detail:
Created Date:  2002-09-10     Completed Date:  2003-04-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8200939     Medline TA:  Liver     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  69-71     Citation Subset:  IM    
Division of Cardiac Surgery, University of Leicester, Glenfield Hospital, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Extracorporeal Membrane Oxygenation*
Liver Failure / therapy
Middle Aged
Multiple Organ Failure / mortality,  therapy*
Prospective Studies
Renal Dialysis*
Retrospective Studies
Sorption Detoxification*
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Emerging indications for MARS dialysis.
Next Document:  Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a pa...